Abstract
Background: Systemic lupus erythematosus (SLE) is currently the most prevalent autoimmune disorder worldwide. A previous study reported the frequency of sarcopenia in patients with chronic inflammation and found a higher rate of sarcopenia in patients with SLE than in control. A preview study found that exercises management given to SLE patients can reduce fatigue and increase vitality.
Objective: The objective of this study is to understand the relationship between sarcopenia and SLE from Physical Medicine and Rehabilitation (PM&R) standpoint and its intervention.
Methods: Using the PubMed computer-aided search engine specific keywords: “sarcopenia” AND “Systemic lupus erythematosus” OR “lupus” OR “SLE” OR “physical medicine and rehabilitation” OR “rehabilitation” OR “physical therapy” OR “exercises” OR “physical activity” OR “training” OR “nutrition” OR “OR “diet.”
Results: Exercise rehabilitation can increase energy level, cardiovascular fitness, functional status, and physical capabilities of muscle strength and are safe to be performed by patients with SLE. Resistance training has been shown to improve muscle strength and size, increase mitochondrial content, and reduce oxidative stress. Resistance exercise impacts sarcopenia through several mechanisms in the muscular and neuromotor levels. Aerobic exercises are also beneficial for skeletal muscles to increase mitochondrial bioenergy, improve insulin sensitivity, and reduce oxidative stresses. Nutritional interventions such as protein, amino acids, essential fatty acids, and vitamin D produce biological effects that will enhance the physiological adaptation of exercise.
Conclusion: Intervention for maintaining muscle function in the prevention and management of sarcopenia in SLE and its complications is a combination of resistance training and nutritional intake through adequate protein intake.
Keywords: autoimmune disorder, chronic inflammation, Physical Medicine and Rehabilitation, rehabilitative management, sarcopenia, systemic lupus erythematosus
Graphical Abstract
[1]
Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: A systematic review of epidemiological studies. Rheumatology 2017; 56(11): 1945-61.
[http://dx.doi.org/10.1093/rheumatology/kex260] [PMID: 28968809]
[http://dx.doi.org/10.1093/rheumatology/kex260] [PMID: 28968809]
[2]
Fatoye F, Gebrye T, Svenson LW. Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada. Rheumatol Int 2018; 38(9): 1721-6.
[http://dx.doi.org/10.1007/s00296-018-4091-4] [PMID: 29987494]
[http://dx.doi.org/10.1007/s00296-018-4091-4] [PMID: 29987494]
[3]
Justiz Vaillant AA, Goyal A, Bansal P, Varacallo M. Systemic Lupus Erythematosus. Treasure Island, FL: StatPearls Publishing 2021.
[4]
Sumantri S, Rengganis I, Laksmi PW, Hidayat R, Koesnoe S, Shatri H. The impact of low muscle function on health-related quality of life in Indonesian women with systemic lupus erythematosus. Lupus 2021; 30(4): 680-6.
[http://dx.doi.org/10.1177/0961203320988595] [PMID: 33470149]
[http://dx.doi.org/10.1177/0961203320988595] [PMID: 33470149]
[5]
Jakes RW, Bae SC, Louthrenoo W, et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pasific region: Prevalence, incidence, clinical features, and mortality. Arthritis Care Res 2012; 64(2): 159-68.
[http://dx.doi.org/10.1002/acr.20683] [PMID: 22052624]
[http://dx.doi.org/10.1002/acr.20683] [PMID: 22052624]
[6]
An HJ, Tizaoui K, Terrazzino S, et al. Sarcopenia in autoimmune and rheumatic diseases: A comprehensive review. Int J Mol Sci 2020; 21(16): 56-78.
[7]
Bae EH, Lim SY, Han KD, et al. Trend of prevalence and incidence of systemic lupus erythematosus in South Korea, 2005 to 2015: A nationwide population-based study. Korean J Intern Med 2020; 35(3): 652-61.
[http://dx.doi.org/10.3904/kjim.2018.303] [PMID: 31212409]
[http://dx.doi.org/10.3904/kjim.2018.303] [PMID: 31212409]
[8]
Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: An update. Curr Opin Rheumatol 2018; 30(2): 144-50.
[http://dx.doi.org/10.1097/BOR.0000000000000480] [PMID: 29251660]
[http://dx.doi.org/10.1097/BOR.0000000000000480] [PMID: 29251660]
[9]
Masakazu W, Chikako K, Akiko O. Epidemiology of systemic
lupus erythematosus, lupus - new advances and challenges. In: Epidemiology
of Systemic Lupus Erythematosus. IntechOpen 2022.
[10]
Wu ML, Yu KH, Tsai JC. The effectiveness of exercises in adult with systemic lupus erythematosus: A systematic review and meta-analysis to guide evidence-based practce. Worldviews Evid Based Nurs 2017; 14(4): 306-15.
[http://dx.doi.org/10.1111/wvn.12221] [PMID: 28432856]
[http://dx.doi.org/10.1111/wvn.12221] [PMID: 28432856]
[11]
Wallace D, Hahn BD. Lupus Erythematosus and Related Syndromes. (9th ed.). Edinburgh: Elsevier Inc 2018; pp. 44-53.
[12]
Sandhu V, Quan M. SLE and serum complement: Causative, concomitant or coincidental? Open Rheumatol J 2017; 11(1): 113-22.
[http://dx.doi.org/10.2174/1874312901711010113] [PMID: 29290848]
[http://dx.doi.org/10.2174/1874312901711010113] [PMID: 29290848]
[13]
Thurman JM, Yapa R. Complement therapeutics in autoimmune disease. Front Immunol 2019; 10: 672.
[http://dx.doi.org/10.3389/fimmu.2019.00672] [PMID: 31001274]
[http://dx.doi.org/10.3389/fimmu.2019.00672] [PMID: 31001274]
[14]
Lopez R, Davidson JE, Beeby MD, Egger PJ, Isenberg DA. Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort. Rheumatology 2012; 51(3): 491-8.
[http://dx.doi.org/10.1093/rheumatology/ker368] [PMID: 22109798]
[http://dx.doi.org/10.1093/rheumatology/ker368] [PMID: 22109798]
[15]
Beckerman NL, Auerbach C, Blanco I. Psychosocial dimensions of SLE: Implications for the health care team. J Multidiscip Healthc 2011; 4: 63-72.
[http://dx.doi.org/10.2147/JMDH.S19303] [PMID: 21594059]
[http://dx.doi.org/10.2147/JMDH.S19303] [PMID: 21594059]
[16]
Williams EM, Kamen D, Penfield M, Oates JC. Stress intervention and disease in African American lupus patients: The balancing lupus experiences with stress strategies (BLESS) study. Health 2014; 6(1): 71-9.
[http://dx.doi.org/10.4236/health.2014.61011] [PMID: 24932382]
[http://dx.doi.org/10.4236/health.2014.61011] [PMID: 24932382]
[17]
Sutrisno RN, Rahmadi AR, Novita N, Hamijoyo L. Most frequent musculoskeletal manifestation of systemic lupus erythematosus patients in Dr. Hasan Sadikin General Hospital Bandung. Ina J Rheum 2017; 9(2): 35-42.
[18]
Andrews JS, Trupin L, Schmajuk G, et al. Muscle strength, muscle mass, and physical disability in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2015; 67(1): 120-7.
[http://dx.doi.org/10.1002/acr.22399] [PMID: 25049114]
[http://dx.doi.org/10.1002/acr.22399] [PMID: 25049114]
[19]
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people. Age Ageing 2010; 39(4): 412-23.
[http://dx.doi.org/10.1093/ageing/afq034] [PMID: 20392703]
[http://dx.doi.org/10.1093/ageing/afq034] [PMID: 20392703]
[20]
Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 2011; 12(6): 403-9.
[http://dx.doi.org/10.1016/j.jamda.2011.04.014] [PMID: 21640657]
[http://dx.doi.org/10.1016/j.jamda.2011.04.014] [PMID: 21640657]
[21]
Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: Consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc 2014; 15(2): 95-101.
[http://dx.doi.org/10.1016/j.jamda.2013.11.025] [PMID: 24461239]
[http://dx.doi.org/10.1016/j.jamda.2013.11.025] [PMID: 24461239]
[22]
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates. Journals of Gerontology: Series A 2014; 69(5): 547-58.
[http://dx.doi.org/10.1093/gerona/glu010] [PMID: 24737557]
[http://dx.doi.org/10.1093/gerona/glu010] [PMID: 24737557]
[23]
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019; 48(1): 16-31.
[http://dx.doi.org/10.1093/ageing/afy169] [PMID: 30312372]
[http://dx.doi.org/10.1093/ageing/afy169] [PMID: 30312372]
[24]
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet 2019; 393(10191): 2636-46.
[http://dx.doi.org/10.1016/S0140-6736(19)31138-9] [PMID: 31171417]
[http://dx.doi.org/10.1016/S0140-6736(19)31138-9] [PMID: 31171417]
[25]
Liguori I, Russo G, Aran L, et al. Sarcopenia: Assessment of disease burden and strategies to improve outcomes. Clin Interv Aging 2018; 13: 913-27.
[http://dx.doi.org/10.2147/CIA.S149232] [PMID: 29785098]
[http://dx.doi.org/10.2147/CIA.S149232] [PMID: 29785098]
[26]
Barone M, Viggiani M, Anelli M, et al. Sarcopenia in patients with rheumatic diseases: Prevalence and associated risk factors. J Clin Med 2018; 7(12): 504.
[http://dx.doi.org/10.3390/jcm7120504] [PMID: 30513782]
[http://dx.doi.org/10.3390/jcm7120504] [PMID: 30513782]
[27]
Ngeuleu A, Allali F, Medrare L, Madhi A, Rkain H, Hajjaj-Hassouni N. Sarcopenia in rheumatoid arthritis: Prevalence, influence of disease activity and associated factors. Rheumatol Int 2017; 37(6): 1015-20.
[http://dx.doi.org/10.1007/s00296-017-3665-x] [PMID: 28258473]
[http://dx.doi.org/10.1007/s00296-017-3665-x] [PMID: 28258473]
[28]
Gupta S, Dhillon RJS, Hasni S. Sarcopenia. Rheum Dis Clin North Am 2018; 44(3): 393-404.
[http://dx.doi.org/10.1016/j.rdc.2018.03.001] [PMID: 30001782]
[http://dx.doi.org/10.1016/j.rdc.2018.03.001] [PMID: 30001782]
[29]
Tuttle CSL, Thang LAN, Maier AB. Markers of inflammation and their association with muscle strength and mass: A systematic review and meta-analysis. Ageing Res Rev 2020; 64: 101185.
[http://dx.doi.org/10.1016/j.arr.2020.101185] [PMID: 32992047]
[http://dx.doi.org/10.1016/j.arr.2020.101185] [PMID: 32992047]
[30]
Santos MJ, Vinagre F, Canas da Silva J, Gil V, Fonseca JE. Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: A comparative study of Caucasian female patients. Clin Exp Rheumatol 2011; 29(3): 470-6.
[PMID: 21640047]
[PMID: 21640047]
[31]
Naito AT, Sumida T, Nomura S, et al. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell 2012; 149(6): 1298-313.
[http://dx.doi.org/10.1016/j.cell.2012.03.047] [PMID: 22682250]
[http://dx.doi.org/10.1016/j.cell.2012.03.047] [PMID: 22682250]
[32]
Yang SW, Kim TH, Choi HM. The reproducibility and validity verification for body composition measuring devices using bioelectrical impedance analysis in Korean adults. J Exerc Rehabil 2018; 14(4): 621-7.
[http://dx.doi.org/10.12965/jer.1836284.142] [PMID: 30276183]
[http://dx.doi.org/10.12965/jer.1836284.142] [PMID: 30276183]
[33]
McPhee JS, French DP, Jackson D, Nazroo J, Pendleton N, Degens H. Physical activity in older age: Perspectives for healthy ageing and frailty. Biogerontology 2016; 17(3): 567-80.
[http://dx.doi.org/10.1007/s10522-016-9641-0] [PMID: 26936444]
[http://dx.doi.org/10.1007/s10522-016-9641-0] [PMID: 26936444]
[34]
Kim TN, Choi KM. Sarcopenia: Definition, epidemiology, and pathophysiology. J Bone Metab 2013; 20(1): 1-10.
[http://dx.doi.org/10.11005/jbm.2013.20.1.1] [PMID: 24524049]
[http://dx.doi.org/10.11005/jbm.2013.20.1.1] [PMID: 24524049]
[35]
Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020; 21(3): 300-307.e2.
[http://dx.doi.org/10.1016/j.jamda.2019.12.012] [PMID: 32033882]
[http://dx.doi.org/10.1016/j.jamda.2019.12.012] [PMID: 32033882]
[36]
Robinson S, Cooper C, Aihie Sayer A. Nutrition and sarcopenia: A review of the evidence and implications for preventive strategies. J Aging Res 2012; 2012: 1-6.
[http://dx.doi.org/10.1155/2012/510801] [PMID: 22506112]
[http://dx.doi.org/10.1155/2012/510801] [PMID: 22506112]
[37]
Bogdanovic G, Stojanovich L, Djokovic A, Stanisavljevic N. Physical activity program is helpful for improving quality of life in patients with systemic lupus erythematosus. Tohoku J Exp Med 2015; 237(3): 193-9.
[http://dx.doi.org/10.1620/tjem.237.193] [PMID: 26490344]
[http://dx.doi.org/10.1620/tjem.237.193] [PMID: 26490344]
[38]
Medicine ACoS. ACSM’s Guidelines for Exercise Testing and Prescription. 10th ed. Philadelphia: Wolters Kluwer Health 2018.Available from: https://www.amazon.com/Guidelines-Exercise-Prescription-American-Medicine/dp/197515018X
[39]
Wu ML, Yu KH, Tsai JC. The effectiveness of exercise in adults with systemic lupus erythematosus: A systematic review and meta-analysis to guide evidence-based practice. Worldviews Evid Based Nurs 2017; 14(4): 306-15.
[http://dx.doi.org/10.1111/wvn.12221] [PMID: 28432856]
[http://dx.doi.org/10.1111/wvn.12221] [PMID: 28432856]
[40]
Rahmatika Handoyo R, Ajoe KT. Therapeutic exercise in systemic lupus erythematosus: Review article. Indones J Phys Med Rehabil 2018; 07: 44-56.
[41]
Candow DG, Forbes SC, Little JP, Cornish SM, Pinkoski C, Chilibeck PD. Effect of nutritional interventions and resistance exercise on aging muscle mass and strength. Biogerontology 2012; 13(4): 345-58.
[http://dx.doi.org/10.1007/s10522-012-9385-4] [PMID: 22684187]
[http://dx.doi.org/10.1007/s10522-012-9385-4] [PMID: 22684187]
[42]
Dalle S, Rossmeislova L, Koppo K. The role of inflammation in age-related sarcopenia. Front Physiol 2017; 8: 1045.
[http://dx.doi.org/10.3389/fphys.2017.01045] [PMID: 29311975]
[http://dx.doi.org/10.3389/fphys.2017.01045] [PMID: 29311975]
[43]
Yuen EP, Bagley JR. Exercise benefits and considerations for individuals with systemic lupus erythematosus. Strength Condit J 2016; 38(6): 69-75.
[http://dx.doi.org/10.1519/SSC.0000000000000261]
[http://dx.doi.org/10.1519/SSC.0000000000000261]
[44]
Constantin MM, Nita IE, Olteanu R, et al. Significance and impact of dietary factors on systemic lupus erythematosus pathogenesis. Exp Ther Med 2019; 17(2): 1085-90.
[PMID: 30679978]
[PMID: 30679978]
[45]
Forbes SC, Little JP, Candow DG. Exercise and nutritional interventions for improving aging muscle health. Endocrine 2012; 42(1): 29-38.
[http://dx.doi.org/10.1007/s12020-012-9676-1] [PMID: 22527891]
[http://dx.doi.org/10.1007/s12020-012-9676-1] [PMID: 22527891]
[46]
Borba-Pinheiro CJ, Almeida de Figueiredo NM, Walsh-Monteiro A, et al. Muscular strength, bone density and body composition of a woman with systemic lupus erythematosus submitted to a resistance training program: A case report. Rev Andal Med Deporte 2012; 5(3): 118-21.
[http://dx.doi.org/10.1016/S1888-7546(12)70018-7]
[http://dx.doi.org/10.1016/S1888-7546(12)70018-7]
[47]
Lucas GM, Ross MJ, Stock PG, et al. Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2014; 59(9): e96-e138.
[http://dx.doi.org/10.1093/cid/ciu617] [PMID: 25234519]
[http://dx.doi.org/10.1093/cid/ciu617] [PMID: 25234519]
[48]
Aparicio-Soto M, Sánchez-Hidalgo M, Alarcón-de-la-Lastra C. An update on diet and nutritional factors in systemic lupus erythematosus management. Nutr Res Rev 2017; 30(1): 118-37.
[http://dx.doi.org/10.1017/S0954422417000026] [PMID: 28294088]
[http://dx.doi.org/10.1017/S0954422417000026] [PMID: 28294088]
[49]
Klack K, Bonfa E, Borba Neto EF. Diet and nutritional aspects in systemic lupus erythematosus. Rev Bras Reumatol 2012; 52(3): 384-408.
[PMID: 22641593]
[PMID: 22641593]
[50]
de Medeiros MCS, Medeiros JCA, de Medeiros HJ, Leitão JCGC, Knackfuss MI. Dietary intervention and health in patients with systemic lupus erythematosus: A systematic review of the evidence. Crit Rev Food Sci Nutr 2019; 59(16): 2666-73.
[http://dx.doi.org/10.1080/10408398.2018.1463966] [PMID: 29648479]
[http://dx.doi.org/10.1080/10408398.2018.1463966] [PMID: 29648479]
Related Books
Natural Products for the Management of Arthritic Disorders
